Literature DB >> 2068157

Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.

P A Voûte1, C A Hoefnagel, J de Kraker, R Valdes Olmos, D J Bakker, A J van de Kleij.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2068157

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  8 in total

Review 1.  Targeted radiotherapy for neuroblastoma.

Authors:  S Meller
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

2.  Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.

Authors:  Alekist Quach; Lingyun Ji; Vikash Mishra; Aimee Sznewajs; Janet Veatch; John Huberty; Benjamin Franc; Richard Sposto; Susan Groshen; Denice Wei; Paul Fitzgerald; John M Maris; Gregory Yanik; Randall A Hawkins; Judith G Villablanca; Katherine K Matthay
Journal:  Pediatr Blood Cancer       Date:  2010-09-09       Impact factor: 3.167

3.  Upfront consolidation treatment with 131I-mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high-risk neuroblastoma.

Authors:  Jianhua Feng; Frankie Wt Cheng; Alex Wk Leung; Vincent Lee; Eva Wm Yeung; Hoi Ching Lam; Jeanny Cheung; Grace Ks Lam; Terry Tw Chow; Carol Ls Yan; Chi Kong Li
Journal:  Pediatr Investig       Date:  2020-09-27

4.  Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.

Authors:  Katherine K Matthay; Alekist Quach; John Huberty; Benjamin L Franc; Randall A Hawkins; Hollie Jackson; Susan Groshen; Suzanne Shusterman; Gregory Yanik; Janet Veatch; Patricia Brophy; Judith G Villablanca; John M Maris
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

Review 5.  Radionuclide therapy revisited.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1991

6.  131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

Authors:  M N Gaze; R J Mairs; S M Boyack; T E Wheldon; A Barrett
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

7.  Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction.

Authors:  R J Mairs; A Livingstone; M N Gaze; T E Wheldon; A Barrett
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

Review 8.  Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.

Authors:  Keri A Streby; Nilay Shah; Mark A Ranalli; Anne Kunkler; Timothy P Cripe
Journal:  Pediatr Blood Cancer       Date:  2014-08-30       Impact factor: 3.167
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.